2:17 PM · 31 January 2025

DE40: DAX holds on to impressive gains ahead of PCE

DE40
Indices
-
-
Novartis
Stocks
NOVN.CH, Novartis AG
-
-
Commerzbank
Stocks
CBK.DE, Commerzbank AG
-
-
  • European stocks gain during Friday's session
  • DAX on ATH ahead of US PCE data

European stock indices traded higher during Wednesday's session. The DAX is currently gaining 0.25% on an intraday basis on the podcast, while France's CAC40 is adding 0.4% over the same period. Investors' attention today turns to corporate news, companies' quarterly results and PCE data from the US.

Volatility currently seen in the European market. Source: xStation

The German DE40 index today extends its previous bullish momentum and breaks out to new historical peaks. The most important support for the index invariably remains the 50-day EMA (blue curve on the chart) and the recent peak broken out by the index in the 20,500-point zone. Technically, the DE40 continues to maintain a stable upward trend all the time. Source: xStation

News

Commerzbank (CBK.DE) is posting a net result of up to €2.7 billion in 2024 (analysts had expected €2.47 billion), while revenues rose 6% to €11.1 billion on the back of strong customer activity, the company reported. Return on equity rose to 9.2% (it was 7.7% in 2023). The dividend is expected to be €0.65 per share. The company's shares are gaining nearly 1% today.

Novartis (NOVN.CH) released financial results showing adjusted net income well above analysts' estimates, as sales of its acclaimed heart failure drug Entresto and newer multiple sclerosis drug Kesimpta exceeded forecasts. Net income for the fourth quarter, adjusted for special items, rose 26% to $3.93 billion (analysts had expected $3.64 billion).

16 October 2025, 6:17 PM

J.B. Hunt gains 18% after strong quarterly results 🚀

16 October 2025, 3:28 PM

Stock of the Week - Lam Research Corp (16.10.2025)

16 October 2025, 3:02 PM

Salesforce surges 8% amid positive long-term revenue forecast📈

16 October 2025, 1:41 PM

Thermo Fisher Scientific announces strategic collaboration with OpenAI📱

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits